⌘K
Loading ticker…
Unicycive Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Unicycive Therapeutics, Inc. Common Stock (UNCY) has a 3-month relative strength percentile of 54 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 58. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 9.3%, relative volume 6.83×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
54 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
UNCY is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $4M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $4M |
| VXFVanguard Extended Market ETF | 0.00% | $1M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | UNCY Jan avg: -1.52% median: 3.58% win: 75% σ: 14.41% n: 4 2022-04-12 → 2026-05-29 | UNCY Feb avg: 10.83% median: 4.20% win: 50% σ: 25.85% n: 4 2022-04-12 → 2026-05-29 | UNCY Mar avg: 76.40% median: 2.23% win: 50% σ: 153.24% n: 4 2022-04-12 → 2026-05-29 | UNCY Apr avg: -11.16% median: -18.84% win: 40% σ: 24.75% n: 5 2022-04-12 → 2026-05-29 | UNCY May avg: -6.05% median: -3.65% win: 40% σ: 10.04% n: 5 2022-04-12 → 2026-05-29 | UNCY Jun avg: -18.12% median: -12.66% win: 0% σ: 17.77% n: 4 2022-04-12 → 2026-05-29 (current) | UNCY Jul avg: -10.31% median: -9.93% win: 0% σ: 1.91% n: 4 2022-04-12 → 2026-05-29 | UNCY Aug avg: -16.59% median: -14.06% win: 0% σ: 14.91% n: 4 2022-04-12 → 2026-05-29 | UNCY Sep avg: 5.46% median: 8.39% win: 75% σ: 15.67% n: 4 2022-04-12 → 2026-05-29 | UNCY Oct avg: 5.84% median: 12.95% win: 75% σ: 27.91% n: 4 2022-04-12 → 2026-05-29 | UNCY Nov avg: 14.07% median: 15.99% win: 75% σ: 22.35% n: 4 2022-04-12 → 2026-05-29 | UNCY Dec avg: 13.25% median: 2.23% win: 50% σ: 42.90% n: 4 2022-04-12 → 2026-05-29 |